Echo Therapeutics, Inc. (ECTE)

Overview

Echo Therapeutics, Inc. specializes in the development of transdermal skin permeation and diagnostic medical devices aimed at enhancing patient care. The company's focus is primarily on the wearable health consumer market, particularly for individuals with diabetes who need outpatient management of their condition. Currently, Echo Therapeutics is advancing an innovative needle-free, wireless Continuous Glucose Monitoring (CGM) system designed specifically for use in hospital settings across the European Union. In addition to its pioneering technology, Echo Therapeutics forms strategic partnerships to broaden its market reach and enhance the development and commercialization of its devices.

Products and Services

• Continuous Glucose Monitoring (CGM) System

  This advanced, needle-free, and wireless CGM technology provides real-time glucose level monitoring tailored for hospital use. The system enables healthcare providers to efficiently manage patients with diabetes, improving overall patient outcomes through continuous data and insights.

• Skin Preparation Devices

  Under a licensing agreement with Ferndale Pharma Group, Echo Therapeutics develops devices that prepare the skin before the application of topical anesthetics or analgesics. These devices help facilitate various needle-based medical procedures, enhancing patient comfort and minimizing pain.